CB-4211

N/A

Report date: 2026/04/19 20:00:14
NME

Base Information

Drug NameCB-4211
Drug Alias NameCB-4211
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInsulin receptor modulators
TargetsInsulin receptor
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCohbar Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCohbar Inc
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A